Literature DB >> 28026970

Engineering 3D-Bioplotted scaffolds to induce aligned extracellular matrix deposition for musculoskeletal soft tissue replacement.

Paul B Warren1,2, Pedro Huebner2,3,4, Jeffrey T Spang5, Rohan A Shirwaiker1,2,3,4, Matthew B Fisher1,2,5.   

Abstract

PURPOSE: Tissue engineering and regenerative medicine approaches have the potential to overcome the challenges associated with current treatment strategies for meniscus injuries. 3D-Bioplotted scaffolds are promising, but have not demonstrated the ability to guide the formation of aligned collagenous matrix in vivo, which is critical for generating functional meniscus tissue. In this study, we evaluate the ability of 3D-Bioplotted scaffold designs with varying interstrand spacing to induce the deposition of aligned matrix in vivo.
MATERIALS AND METHODS: 3D-Bioplotted polycaprolactone scaffolds with 100, 200, or 400 μm interstrand spacing were implanted subcutaneously in a rat model for 4, 8, or 12 weeks. Scaffolds were harvested, paraffin-embedded, sectioned, and stained to visualize cell nuclei and collagen. Quantitative image analysis was used to evaluate cell density, matrix fill, and collagen fiber alignment within the scaffolds.
RESULTS: By 4 weeks, cells had infiltrated the innermost scaffold regions. Similarly, collagenous matrix filled interstrand regions nearly completely by 4 weeks. By 12 weeks, aligned collagen was present in all scaffolds. Generally, alignment along the scaffold strands increased over time for all three interstrand spacing groups. Distribution of collagen fiber alignment angles narrowed as interstrand spacing decreased.
CONCLUSIONS: 3D-Bioplotted scaffolds allow for complete cell infiltration and collagenous matrix production throughout the scaffold. The ability to use interstrand spacing as a means of controlling the formation of aligned collagen in vivo was demonstrated, which helps establish a design space for scaffold-based meniscus tissue engineering.

Entities:  

Keywords:  3D printing; Biofabrication; meniscus; scaffold; tissue engineering

Mesh:

Substances:

Year:  2016        PMID: 28026970     DOI: 10.1080/03008207.2016.1276177

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  6 in total

1.  Considerations for translation of tissue engineered fibrocartilage from bench to bedside.

Authors:  Ryan P Donahue; Erik A Gonzalez-Leon; Jerry C Hu; Kyriacos Athanasiou
Journal:  J Biomech Eng       Date:  2018-12-05       Impact factor: 2.097

Review 2.  Meniscus regeneration by 3D printing technologies: Current advances and future perspectives.

Authors:  Elena Stocco; Andrea Porzionato; Enrico De Rose; Silvia Barbon; Raffaele De Caro; Veronica Macchi
Journal:  J Tissue Eng       Date:  2022-01-25       Impact factor: 7.813

3.  Multiscale Anisotropic Tissue Biofabrication via Bulk Acoustic Patterning of Cells and Functional Additives in Hybrid Bioinks.

Authors:  Parth Chansoria; Suleman Asif; Nithin Gupta; Jorge Piedrahita; Rohan A Shirwaiker
Journal:  Adv Healthc Mater       Date:  2022-01-27       Impact factor: 11.092

4.  High-Throughput Manufacture of 3D Fiber Scaffolds for Regenerative Medicine.

Authors:  Rohan A Shirwaiker; Matthew B Fisher; Bruce Anderson; Karl G Schuchard; Paul B Warren; Benoit Maze; Pierre Grondin; Frances S Ligler; Behnam Pourdeyhimi
Journal:  Tissue Eng Part C Methods       Date:  2020-07       Impact factor: 3.056

5.  Potential of Melt Electrowritten Scaffolds Seeded with Meniscus Cells and Mesenchymal Stromal Cells.

Authors:  Jasmijn V Korpershoek; Mylène de Ruijter; Bastiaan F Terhaard; Michella H Hagmeijer; Daniël B F Saris; Miguel Castilho; Jos Malda; Lucienne A Vonk
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

Review 6.  From intricate to integrated: Biofabrication of articulating joints.

Authors:  Wilhelmina Margaretha Groen; Paweena Diloksumpan; Paul René van Weeren; Riccardo Levato; Jos Malda
Journal:  J Orthop Res       Date:  2017-06-16       Impact factor: 3.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.